MK-0736

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HypertensionPeripheral Vascular DiseasesType 2 Diabetes Mellitus

Phase 1

A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)

TerminatedNCT00679055

Merck Sharp & Dohme LLCPeripheral Vascular Diseases

Start: 2007-03-31End: 2008-08-26Updated: 2018-08-17

Phase 2

Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)

TerminatedNCT00806585

Merck Sharp & Dohme LLCHypertension, Type 2 Diabetes Mellitus

Start: 2008-12-31End: 2010-06-30Updated: 2015-09-21